ClinicalTrials.gg
CompletedNCT07871032Updated Oct 13, 2026

Climate Change Education Based on the IMB Model for Pregnant Women

An interventional study of IMB-Based Climate Change Education in Pregnancy, Climate Change Anxiety and Risk Perception, sponsored by Cukurova University. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by Cukurova University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Oct 2025, registered Oct 2026).
Updated Oct 13, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Study summary

Climate change can affect the health of pregnant women and their babies, for example through extreme heat and air pollution. Many pregnant women worry about these effects but do not know how to protect themselves. This study tested whether a short education program could help pregnant women understand these risks and learn practical ways to protect their health. Pregnant women attending an antenatal education class took part in one group education session lasting about one hour. The session covered how climate change affects pregnancy and newborn health, helped women think about their own risks, and taught simple protective steps, such as staying safe on very hot days and on days with poor air quality. Women completed questionnaires before the session and again four weeks later. The study looked at changes in their awareness of climate change, their worry about climate change, how risky they felt their pregnancy was, and their fear of childbirth.

02

Conditions studied

  • Pregnancy
  • Climate Change Anxiety
  • Risk Perception
  • Fear of Childbirth
03

In context

Lead sponsor

Cukurova University is the lead sponsor of 258 studies on the registry; 49 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18 years or older
  • Confirmed pregnancy in the second or third trimester
  • Able to read, write, and understand Turkish
  • Attending the antenatal education class of the study hospital
  • Willing to participate and providing written informed consent

Exclusion criteria

Exclusion Criteria:

  • Diagnosis of high-risk pregnancy (e.g., preeclampsia, multiple pregnancy)
  • Known chronic medical condition
  • Previous participation in any training program on climate change
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    IMB-Based Education Group

    Pregnant women received a single group education session (50-60 minutes) based on the Information-Motivation-Behavioral Skills model, supported by a presentation and an educational booklet. Outcomes were assessed before the session and four weeks later.

    Behavioral: IMB-Based Climate Change Education

Interventions

  • BehavioralIMB-Based Climate Change Education

    A nurse-led group education session for 4-6 pregnant women, based on the Information-Motivation-Behavioral Skills model. The information component covered climate change and its effects on pregnancy and fetal health; the motivation component included a personal risk assessment focused on protecting maternal and infant health; and the behavioral skills component covered practical steps for coping with extreme heat, poor air quality, nutrition, and water consumption. Participants received the booklet "Climate Change Adaptation Guide for Pregnant Women" at the end of the session. No additional training or reminders were given during the four-week follow-up.

06

What researchers measure

Primary outcomes

  1. Change in Climate Change Anxiety

    Measured with the Climate Change Anxiety Scale for Women's Health (18 items, 5-point Likert). Total scores range from 18 to 90; higher scores indicate greater climate change anxiety.

    Time frame: Baseline (before the education session) and 4 weeks after the session

Secondary outcomes

  1. Change in Climate Change Awareness

    Measured with the Pregnancy-Specific Climate Change Awareness Scale (21 items, 5-point Likert). Total scores range from 21 to 105; higher scores indicate greater awareness of the effects of climate change on health.

    Time frame: Baseline (before the education session) and 4 weeks after the session

  2. Change in Perception of Pregnancy Risk

    Measured with the Perception of Pregnancy Risk Questionnaire (9 items, visual analog scale). The total score is the mean of the items and ranges from 0 to 10; higher scores indicate greater perceived risk to oneself and the baby.

    Time frame: Baseline (before the education session) and 4 weeks after the session

  3. Change in attitude of Childbirth

    Measured with the Childbirth Attitudes Questionnaire (16 items, 4-point Likert). Total scores range from 16 to 64; higher scores indicate greater fear of childbirth.

    Time frame: Baseline (before the education session) and 4 weeks after the session

07

Study locations

1 site
  • Şırnak Maternity and Children's Hospital
    Şırnak, Turkey (Türkiye)
08

References and documents

Publications

  • Kaya L, Keles E, Baydili KN, Kaya Z, Kumru P. Impact of Climate Change Education on Pregnant Women's Anxiety and Awareness. Public Health Nurs. 2025 Jan-Feb;42(1):54-60. doi: 10.1111/phn.13455. Epub 2024 Oct 10. PubMed 39388505 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared publicly, as participants did not provide consent for data sharing beyond the research team. De-identified data may be made available by the corresponding author upon reasonable request and with approval from the ethics committee.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2025 to primary completion in Aug 2026, 9 months.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 7, 2026
First posted
Oct 13, 2026
StartActual
Oct 20, 2025
Primary completionActual
Aug 15, 2026
CompletionActual
Aug 15, 2026
Last update
Oct 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07871032
Responsible party
MÜJDE KERKEZ (Assoc. Prof., Cukurova University) — Principal investigator
First posted
Oct 13, 2026
Start date
Oct 20, 2025
Primary completion
Aug 15, 2026
Completion
Aug 15, 2026
Last update
Oct 13, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion